BC Innovations | Apr 18, 2013
Distillery Therapeutics

Indication: Renal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Renal disease MicroRNA-193a (miR-193a) Patient tissue and mouse studies suggest antagonizing miR-193a could help treat focal segmental glomerulosclerosis (FSGS), which can lead to renal...
Items per page:
1 - 1 of 1